
To reduce the inconvenience of medication for patients during burn wound healing, developing a novel drug delivery system is highly significant. In this study, we developed lysozyme-loaded hydrogel microneedles incorporating methacrylated hyaluronic acid (HAMA) into the needle matrix. We observed the morphological structure of the microneedles using a stereomicroscope and a scanning electron microscope, and characterized the materials by means of X-ray diffraction (XRD), infrared spectroscopy and Differential scanning calorimetry (DSC). Furthermore, the in vitro release and in vitro antibacterial ability of the lysozyme hydrogel microneedles were studied. Finally, the application of these microneedles in the healing of animal burn wounds was carried out. Upon subcutaneous application, the hydrogel interacts with the tissue and gradually releases lysozyme. Compared with traditional topical application drug delivery, these microneedles demonstrate higher subcutaneous penetration efficiency and a sustained-release profile. In vivo experiments on burn wound healing further confirmed that the lysozyme hydrogel microneedles significantly enhance the healing process. The designed microneedles are both convenient and efficient, offering a promising new approach for burn wound treatment.
Acetaminophen (ACM) and caffeine (CAF) are frequently co‑administered for rapid analgesic relief for migraines, and transdermal delivery of these over-the-counter therapies could improve the patient at-home experience. In this 2-part series we examine the impact of formulation and physical enhancements on ACM and CAF skin transport. Here in part 1, we examined how polymer and solid microneedle pretreatment influence ACM and CAF release and dermal permeation from hydroxyethyl cellulose and polyvinylpyrrolidone gels. Part 2 examines impacts of dissolving microneedles and applied heat. Methods: FTIR was used to assess potential interactions between the active pharmaceutical ingredients (APIs) and polymers. Viscosity and viscoelastic parameters (G′ and G″) of the polymeric gels were measured on a rheometer. Diffusion studies were performed to quantify API release and permeation through dermatomed porcine skin, from single or dual-API loaded gels. Transepidermal water loss (TEWL) studies measured skin barrier disruption after microneedle application. Results: FTIR confirmed that both drugs remained chemically unchanged in each polymer matrix, indicating no strong drug-polymer interactions. Microneedle pretreatment significantly enhanced permeation for all formulations, with varying levels of enhancement for individual vs co‑API gels. Impact of co-delivery on permeation was dependent on API, polymer, and timing. Conclusions: Polymer structure, co-delivery, and microchannel‑mediated transport all influenced ACM and CAF delivery across intact and solid microneedle-treated skin.
Antibiotic resistance has intensified the need for alternative therapies, such as bacteriophage administration. However, the optimal delivery strategy—specifically simultaneous versus sequential dosing—remains poorly defined for ensuring sustainable efficacy. This single-strain, in vitro proof-of-concept study evaluated receptor-targeted sequential dosing using phages Dobby, targeting lipopolysaccharide, and MPK7, targeting type IV pili, against P. aeruginosa PAO1. Time-kill assays were conducted at various multiplicities of infection (MOI: 0.01, 1, and 100) to compare simultaneous and sequential dosing regimens. Resistance profiling was performed to assess the fitness costs of resulting isolates, while atomic force microscopy infrared spectroscopy (AFM-IR) was utilized to identify chemical signatures and underlying resistance mechanisms in phage-resistant mutants. Sequential treatment, particularly initiating therapy with the LPS-specific phage Dobby followed by MPK7, was more effective than simultaneous dosing, achieving bacterial reductions exceeding 3-log10 within 48 h. Notably, low MOI (0.01) sequential treatments maintained sustained population suppression, whereas high MOI (100) treatments triggered rapid bacterial rebound. Resistance profiling confirmed that Dobby-resistant isolates exhibited lower fitness costs, rendering them more susceptible to subsequent MPK7 treatment. AFM-IR revealed unique chemical alterations in resistant mutants, specifically linked to LPS truncation and TFP dysfunction. In the Dobby–MPK7–PAO1 model, receptor-specific sequential dosing produced more sustained bacterial suppression than simultaneous treatment. This proof-of-concept supports further evaluation of temporal phage dosing across diverse P. aeruginosa strains and phage combinations.
LBURGINAZE™ is an engineered human arginase-1 fusion protein developed to exploit tumor metabolic vulnerabilities via systemic arginine depletion. Developing a stable formulation is necessary to preserve its enzymatic activity during long-term storage and clinical translation. Thus, this study aimed to systematically screen excipients and rationally develop aqueous and lyophilized formulations of LBURGINAZE. A panel of pharmaceutically acceptable excipients, including sugars, polyols, and amino acids, was screened under thermal stress at 25℃ by measuring arginine hydrolytic activity. Formulations were evaluated in both liquid and freeze-dried states, with lead single excipients that preserved catalytic activity subsequently incorporated into multi-component formulations. Following stability assessments, the biological potency of reconstituted LBURGINAZE was evaluated against 3D HepG2 hepatocellular carcinoma spheroids alone and in combination with the multi-kinase inhibitor sorafenib. In aqueous state, a multi-component formulation containing glycerol, L-alanine, NaCl, and polysorbate 80 provided optimal stability, preserving catalytic activity over 4 weeks. For solid-state storage, a single-excipient lyophilization containing sucrose provided superior lyoprotection, effectively maintaining 100
NONMEM is the gold-standard tool in pharmacometrics, yet much of its estimation engine operates out of sight. Routine outputs show what the engine reports, but not everything it computes along the way. The quantities needed to answer a specific question may exist transiently within the long-established Fortran-based engine, but for most modelers they remain hidden behind an implementation barrier. AI-assisted modeling changes that barrier. A user can pose a question in “vibe” language, work with an AI assistant to generate verbatim Fortran code that instruments the running engine and exposes otherwise unavailable quantities on demand for use as additional model diagnostics or in other ad hoc investigations. We illustrate this capability with two examples: capturing how subject-level samples evolve from one iteration to the next during NONMEM’s expectation-maximization (EM) methods, including importance sampling (IMP) and stochastic approximation expectation maximization (SAEM), and tracking the BFGS Hessian approximation and objective-function gradients across snapshots of first-order conditional estimation (FOCE). The examples themselves are not the central contribution. Rather, they demonstrate how AI can turn NONMEM from a closed black box into an engine that motivated users can interrogate when new questions arise. When paired with scientific judgment and numerical verification, AI can make forms of engine-level inspection once largely limited to developers and specialized experts accessible to everyday modelers, substantially shortening the distance between a NONMEM user and a NONMEM expert.